The preoperative prognostic value of the radiomics nomogram based on CT combined with machine learning in patients with intrahepatic cholangiocarcinoma

被引:22
作者
Tang, Youyin [1 ]
Zhang, Tao [2 ]
Zhou, Xianghong [3 ]
Zhao, Yunuo [2 ]
Xu, Hanyue [2 ]
Liu, Yichun [4 ]
Wang, Hang [5 ]
Chen, Zheyu [6 ]
Ma, Xuelei [3 ,7 ]
机构
[1] Sichuan Univ, Liver Transplantat Ctr, Dept Liver Surg, West China Hosp, 37 GuoXue Alley, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, West China Sch Med, 37 GuoXue Alley, Chengdu 610041, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Biotherapy, 37 GuoXue Alley, Chengdu 610041, Peoples R China
[4] Sichuan Univ, West China Teaching Hosp 4, West China Sch Publ Hlth, Three Sect People South Rd, Chengdu 610041, Peoples R China
[5] Sichuan Univ, West China Hosp, West China Sch Med, 14 3rd Sect Ren Min Nan Rd, Chengdu 610041, Peoples R China
[6] Sichuan Univ, West China Hosp, Div Liver Transplantat Ctr, Dept Liver Surg, 37 GuoXue Alley, Chengdu 610041, Peoples R China
[7] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, 37 GuoXue Alley, Chengdu 610041, Peoples R China
关键词
Intrahepatic cholangiocarcinoma; Radiomics; Nomogram; Prognosis; Machine learning; TEXTURE ANALYSIS; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CANCER; LIVER; SURVIVAL; FEATURES; IMAGES; PET;
D O I
10.1186/s12957-021-02162-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Intrahepatic cholangiocarcinoma is an aggressive liver carcinoma with increasing incidence and mortality. A good auxiliary prognostic prediction tool is desperately needed for the development of treatment strategies. The purpose of this study was to explore the prognostic value of the radiomics nomogram based on enhanced CT in intrahepatic cholangiocarcinoma. Methods In this retrospective study, 101 patients with pathological confirmation of intrahepatic cholangiocarcinoma were recruited. A radiomics nomogram was developed by radiomics score and independent clinical risk factors selecting from multivariate Cox regression. All patients were stratified as high risk and low risk by a nomogram. Model performance and clinical usefulness were assessed by calibration curve, ROC curve, and survival curve. Results A total of 101patients (mean age, 58.2 years old; range 36-79 years old) were included in the study. The 1-year, 3-year, and 5-year overall survival rates were 49.5%, 26.6%, and 14.4%, respectively, with a median survival time of 12.2 months in the whole set. The least absolute shrinkage and selection operator (LASSO) method selected 3 features. Multivariate Cox analysis found three independent prognostic factors. The radiomics nomogram showed a significant prognosis value with overall survival. There was a significant difference in the 1-year and 3-year survival rates of stratified high-risk and low-risk patients in the whole set (30.4% vs. 56.4% and 13.0% vs. 30.6%, respectively, p = 0.018). Conclusions This radiomics nomogram has potential application value in the preoperative prognostic prediction of intrahepatic cholangiocarcinoma and may facilitate in clinical decision-making.
引用
收藏
页数:13
相关论文
共 50 条
[1]   Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma [J].
Bagante, Fabio ;
Weiss, Matthew ;
Alexandrescu, Sorin ;
Marques, Hugo P. ;
Aldrighetti, Luca ;
Maithel, Shishir K. ;
Pulitano, Carlo ;
Bauer, Todd W. ;
Shen, Feng ;
Poultsides, George A. ;
Soubrane, Olivier ;
Martel, Guillaume ;
Koerkamp, Bas G. ;
Guglielmi, Alfredo ;
Itaru, Endo ;
Pawlik, Timothy M. .
HPB, 2018, 20 (12) :1189-1197
[2]   Nomograms in oncology: more than meets the eye [J].
Balachandran, Vinod P. ;
Gonen, Mithat ;
Smith, J. Joshua ;
DeMatteo, Ronald P. .
LANCET ONCOLOGY, 2015, 16 (04) :E173-E180
[3]   Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective Study [J].
Bargellini, Irene ;
Mosconi, Cristina ;
Pizzi, Giuseppe ;
Lorenzoni, Giulia ;
Vivaldi, Caterina ;
Cappelli, Alberta ;
Vallati, Giulio E. ;
Boni, Giuseppe ;
Cappelli, Federico ;
Paladini, Andrea ;
Sciuto, Rosa ;
Masi, Gianluca ;
Golfieri, Rita ;
Cioni, Roberto .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 43 (09) :1305-1314
[4]   Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma [J].
Bridgewater, John ;
Galle, Peter R. ;
Khan, Shahid A. ;
Llovet, Josep M. ;
Park, Joong-Won ;
Patel, Tushar ;
Pawlik, Timothy M. ;
Gores, Gregory J. .
JOURNAL OF HEPATOLOGY, 2014, 60 (06) :1268-1289
[5]   Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT [J].
Brown, P. J. ;
Zhong, J. ;
Frood, R. ;
Currie, S. ;
Gilbert, A. ;
Appelt, A. L. ;
Sebag-Montefiore, D. ;
Scarsbrook, A. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (13) :2790-2799
[6]   Texture analysis of medical images [J].
Castellano, G ;
Bonilha, L ;
Li, LM ;
Cendes, F .
CLINICAL RADIOLOGY, 2004, 59 (12) :1061-1069
[7]   Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma [J].
Chaisaingmongkol, Jittiporn ;
Budhu, Anuradha ;
Dang, Hien ;
Rabibhadana, Siritida ;
Pupacdi, Benjarath ;
Kwon, So Mee ;
Forgues, Marshonna ;
Pomyen, Yotsawat ;
Bhudhisawasdi, Vajarabhongsa ;
Lertprasertsuke, Nirush ;
Chotirosniramit, Anon ;
Pairojkul, Chawalit ;
Auewarakul, Chirayu U. ;
Sricharunrat, Thaniya ;
Phornphutkul, Kannika ;
Sangrajrang, Suleeporn ;
Cam, Maggie ;
He, Ping ;
Hewitt, Stephen M. ;
Ylaya, Kris ;
Wu, Xiaolin ;
Andersen, Jesper B. ;
Thorgeirsson, Snorri S. ;
Waterfall, Joshua J. ;
Zhu, Yuelin J. ;
Walling, Jennifer ;
Stevenson, Holly S. ;
Edelman, Daniel ;
Meltzer, Paul S. ;
Loffredo, Christopher A. ;
Hama, Natsuko ;
Shibata, Tatsuhiro ;
Wiltrout, Robert H. ;
Harris, Curtis C. ;
Mahidol, Chulabhorn ;
Ruchirawat, Mathuros ;
Wang, Xin W. .
CANCER CELL, 2017, 32 (01) :57-+
[8]   Prognostic value of site-specific metastases for patients with advanced intrahepatic cholangiocarcinoma A SEER database analysis [J].
Cheng, Rui ;
Du, Qiang ;
Ye, Jingmin ;
Wang, Bi ;
Chen, Yanling .
MEDICINE, 2019, 98 (49)
[9]  
Cheng W, 2015, INT J CLIN EXP PATHO, V8, P15511
[10]   Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies [J].
Cidon, E. Una .
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 :43-48